False Claim Not Apparent To 2nd Circ. In Lipitor Suit
The Second Circuit struggled Monday to determine where a false claim for reimbursement may have been submitted for Pfizer's anti-cholesterol drug Lipitor as a plaintiff sought to revive his decade-old qui...To view the full article, register now.
Already a subscriber? Click here to view full article